Priming the Tumor Immune Microenvironment Improves Immune Surveillance of Cancer Stem Cells and Prevents Cancer Recurrence

Abstract

Here, we report that Tumor-associated macrophages (TAMs) promote Cancer stem cell (CSC) -like phenotypes in murine breast cancer cells by up regulating their expression of Sox-2, resistance to chemotherapy, and increased tumorigenicity. Down regulation of Sox-2 in tumors blocked the ability of TAMs to induce these CSC-like phenotypes and inhibited tumor growth. We identified a novel EGFR/ Stat3/Sox-2 paracrine signaling pathway between macrophages and breast cancer cells and showed that this crosstalk was effectively blocked by small molecule inhibitors AG1478 or CDDO-Im against EGFR and Stat3, respectively. Therefore, our study identifies a novel role for TAMs in breast CSC regulation and establishes a rationale for targeting the EGFR/Stat3/Sox-2 signaling pathway for CSC therapy. Intratumoral injection of miR-19a-3p impaired the capacity of breast tumor cells to migrate and invade, suggesting it to play a critical role in induction of macrophage polarization and to be a useful therapeutic target for remodeling the tumor immune environment and thereby improve treatment of breast cancer.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2013
Accession Number
ADA594027

Entities

People

  • Ralph A. Reisfeld
  • Yunping Luo

Organizations

  • Scripps Research

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Biological Sciences
  • Blood
  • Breast Cancer
  • Cancer
  • Cell Movement
  • Cells
  • Chemistry
  • Chemotherapy
  • Culture Techniques
  • Gene Expression
  • Medical Personnel
  • Peptide Growth Factors
  • Proteins
  • Small Molecules
  • Stem Cells
  • Tumor Cell Line

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Oncology (Cancer Research).

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech